Standout Papers

Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19：a meta-an... 2022 2026 2023 2024260
  1. Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19：a meta-analysis (2022)
    Wen Wen, Chen Chen et al. Annals of Medicine

Immediate Impact

36 standout
Sub-graph 1 of 13

Citing Papers

Guidelines for accurate application of green and white analytical concepts: Merits Versus demerits with insights of significant milestones of assessment tools applied for antiviral drugs
2024 Standout
Non-invasive Scores and Serum Biomarkers for Fatty Liver in the Era of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): A Comprehensive Review From NAFLD to MAFLD and MASLD
2024 Standout
2 intermediate papers

Works of Jiake Tang being referenced

Metabolic dysfunction-associated fatty liver disease and cardiovascular disease: A meta-analysis
2022
Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19：a meta-analysis
2022 Standout

Author Peers

Author Last Decade Papers Cites
Jiake Tang 89 14 36 213 64 22 380
Chen Chen 67 6 15 213 64 17 444
Zhongde Zhang 38 8 16 102 28 34 435
Babak Ebrahimi 43 18 23 211 119 17 379
Nadia Soudani 125 37 5 168 36 23 438
Bahman Amani 42 16 6 278 101 25 424
Irma Convertino 35 9 6 179 33 29 376
Kishan Patel 101 21 13 204 50 27 431
Neda Ghaffari 47 21 13 204 113 18 414
Radu Mitruţ 45 21 19 99 61 29 431
Hui Zhu 50 6 12 181 53 33 373

All Works

Loading papers...

Rankless by CCL
2026